Targeting of naproxen covalently linked to HSA to sinusoidal cell types of the liver

Journal of Drug Targeting

Volumn 5, Issue 5, 1998, Pages 329-342

  Melgert, B N ^a   Wartna, E ^a   Lebbe, C ^b   Albrecht, C ^b   Molema, G ^a   Poelstra, K ^a   Reichen, J ^b   Meijer, D K F ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Albumin; Hepatic delivery; Inflammatory liver diseases; Naproxen; Sinusoidal cells

Indexed keywords

DRUG METABOLITE; HUMAN SERUM ALBUMIN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DEGRADATION; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG TARGETING; ENDOTHELIUM CELL; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LIVER CELL; LIVER DISEASE; LIVER SINUSOID; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SIDE EFFECT;

EID: 0031708349     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869808997861     Document Type: Article

References (36)

1. Albrecht C., Meijer D.K.F., Sägesser H. and Reichen J. (1996) Targeting naproxen to endothelial (EC) and kuppfer cells (KC) protects against endotoxin in biliary cirrhosis (BC) in vivo. Hepatology, 24, 187A(Abstract)
2. Albrecht C., Reichen R., Visser J., Meijer D.K.F. and Thormann W. (1997) Differentiation between naproxen, naproxen-protein-conjugates and naproxen-lysine in plasma via micellar electrokinetic capillary chromatography - a new approach in the bioanalysis of drug targeting preparations. Clin. Chem., (In press)
3. Anderson G.W., Zimmerman J.E. and Callahan F.M. (1964) The use of esters of N-Hydroxysuccinimide in Peptide Synthesis. J. Am. Chem. Soc., 86, 1839-1842.
4. Arai M., Mochida S., Ohno A., Ogata I. and Fujiwara K. (1993) Sinusoidal Endothelial Cell Damage by Activated Macrophages in Rat Liver Necrosis. Gastroenterology, 104, 1466-1471.
5. Bernard A., Viau C., Ouled A. and Lauwerijs ? (1987) Competition between low- and high molecular weight proteins for renal tubular uptake. Nephron, 45, 115-118.
6. Braakman I., Groothuis G.M.M. and Meijer D.K.F. (1989) Zonal compartmentation of perfused rat liver: plasma reappearance of rhodamine B explained. J. Pharmacol. Exp. Ther., 249, 869-873.
7. Burt A.D. (1993) Cellular and Molecular Aspects of Hepatic Fibrosis. J. Pathol., 170, 105-114.
8. Buys C.H.C.M., Elferink M.G.L., Bouma J.M.W., Gruher M. and Nieuwenhuis P. (1973) Protcolysis of formaldehyde-treated albumin in Kupffer cells and its inhibition by suramin. J. Reticuloendothel. Soc., 14, 209-223.
9. Decker K. (1990) The macrophages and their signal products. In Infectious Diseases of the Liver, L. Bianchi, K.-P. Maier, W. Gerok and F. Deinhardt (eds), Kluwer Academic Publishers, Dordrecht/Boston/London, pp. 49-71.
10. Edward M.J. (1993) The Involvement of Kupffer Cells in CCL(4) toxicity. Toxicol. Appl. Pharmacol., 119, 275-279.
11. Franssen E.J.F., Van Amsterdam R.G.M., Visser J., Moolenaar F., De Zeeuw D. and Meijer D.K.F. (1991) Low molecular weight proteins as carriers for renal drug targeting: Naproxen-Lysozyme. Pharm. Res., 8, 1223-1230.
12. Franssen E.J.F., Koiter J., Kuipers C.A.M., Bruins A.P., Moolenaar F., De Zeeuw D., Kruizinga W.H., Kellogg R.M. and Meijer D.K.F. (1992) Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates. J Med. Chem., 35, 1246-1259.
13. Franssen E.J.F., Jansen R.W., Vaalburg M. and Meijer D.K.F. (1993) Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules. Biochem. Pharmacol., 45, 1215-226.
14. Friedman S.L., Flier J.S., Epstein F., Glickman R. and Scheele G. (1993) Seminars in Medicine of the Beth Israel Hospital, Boston - The Cellular Basis of Hepatic Fibrosis - Mechanisms and Treatment Strategies. N. Engl. J. Med., 328, 1828-1835.
15. Greenwel P., Geerts A., Ogata I., Solis-Herruzo J.-A., and Rojkind M. (1994) Liver fibrosis. In The Liver: Biology and Pathobiology, Third edition, I.M. Arias, J.L. Boyer, N. Fausto, W.B. Jakoby, D.A. Schachter and D.A. Shafritz (eds), Raven Press, Ltd. New York, pp. 1367-1381.
16. Grolleman C.W.J., Visser A.C., Wolke J.G.C., Van der Goot H. and Timmerman H. (1986) Studies on a bioerodible drug carrier system based on a polyphosphazene. Part 1. Synthesis. J. Contr. Rel., 3, 143-154.
17. Halushka P.V., Wise W.C. and Cook J.A. (1981) Protective effects of aspirin in endotoxic shock. J. Pharmacol, Exp. Ther., 218, 464-469.
18. Honn K.V. and Marnett L.J. (1984) Prostaglandin, thromboxane, and leukotrine biosynthesis: target for antitumor and antimetastatic agents. In Novel Approaches to Cancer Chemotherapy, P.S. Sunkara (ed), Academic Press, Inc. Orlando (Fla), pp. 127-163.
19. 125I-ligands among the liver cell types. J. Cell Biol., 83, 47-64.
20. Jansen R.W., Molema G., Harms G., Kruijt J.K., Van Berkel T.J.C., Hardonk M.J. and Meijer D.K.F. (1991) Formaldehyde treated albumin contains monomeric and polymeric forms that are differently cleared by endothelial and Kupffer cells of the liver: evidence tor scavenger receptor heterogeneity. Biochem. Biophys. Res. Commun., 180, 23-32.
21. Jonker A.M., Dijkhuis F.W.J., Grond J., and Hardonk M.J. (1993) Kupffer Cell Depletion attenuates Acute D-Galactosamine-Induced Hepatitis in Rats. In Galactosamine-induced liver disease, Thesis edition, A.M. Jonker (ed), University of Groningen, Groningen, pp. 47-60.
22. Kawada N., Mizoguchi Y., Sakagami Y., Kobayashi K., Yamamoto S. and Morisawa S. (1990) Changes in leukotrienes and prostaglandins in the liver tissue of rats in the experimental massive hepatic cell necrosis model. Prostaglandins Leukot. Essent. Fatty Acids, 40, 149-155.
23. Kitchen F.A., Dawson W., Rainsford K.D. and Cawston T. (1985) Inflammation and possible modes of action of anti-inflammatory drugs. In Volume I: Inflammation mechanisms and actions of traditional drugs, K.D. Rainsford and M.R.C. Path (eds), CRC Press, Inc. Boca Raton, pp. 21-87.
24. Laskin D.L., Feder L.S., Mccloskey T.W. and Gardner C.R. (1991) Role of Nonparenchymal Cells in Hepatotoxicity. In Cells of the Hepatic Sinusoid, Vol. 3, E. Wisse, D.L. Knook and R.S. McCuskey (eds), Kupffer Cell Foundation, Leiden, pp. 81-83.
25. Lebbe C., Reichen J., Wartna E., Saegesser H., Poelstra K. and Meijer D.K.F. (1997) Targeting naproxen to non-parenchymal liver cells protects against endotoxin induced liver damage. Journal of Drug Targeting, 4(5), 303-310.
26. Maher J.J. (1993) Cell-Specific Expression of Hepatocyte Growth Factor in Liver - Upregulation in Sinusoidal Endothelial Cells After Carbon Tetrachloride. J. Clin. Invest., 91, 2244-2252.
27. Meijer D.K.F., Keulemans K. and Mulder G.J. (1981) Isolated perfused rat liver technique. Methods Enzymol., 77, 81-94.
28. Meijer D.K.F. and Molema G. (1995) Targeting of drugs to the liver. Semin. Liver Dis., 15, 202-256.
29. Rieder H., Meyer zum Büschenfelde K.-H. and Ramadori G. (1992) Functional spectrum of sinusoidal endothelial liver cells. Filtration, endocytosis, synthetic capacities and intercellular communication. J. Hepatol., 15, 237-250.
30. Rieder H., Armbrust T., Zumbuschenfelde K.H.M. and Ramadori G. (1993) Contribution of Sinusoidal Endothelial Liver Cells to Liver Fibrosis - Expression of Transforming Growth Factor-beta-1 Receptors and Modulation of Plasmin-Generating Enzymes by Transforming Growth Factor-beta/1. Hepatology, 18, 937-944.
31. Robertson M. (1990) The New Biology of Immune Recognition. Nature, 348, 281-282.
32. Runkel R., Chaplin M., Boost G., Segre E. and Forchielli ? (1972) Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J. Pharm. Sci., 61, 703-708.
33. Scaf A.H.J. (1988) Pharmacokinetic analysis with RUGFIT: an interactive pharmacokinetic computer program. Biopharm. Drug Dispos., 9, 415-446.
34. Segre E.J. (1983) Naproxen. In Anti-Rheumatic Drugs, E.C. Huskisson (ed), Praeger Publishers, New York, pp. 401-420.
35. Skogh T., Stendahl O., Sundqvist T. and Edebo L. (1983) Physicochemical properties and blood clearance of human serum albumin conjugated to different extents with dinitrophenyl groups. Int. Arch. Allergy Appl. Immunol., 70, 238-244.
36. Summerfield J.A., Vergalla J. and Jones A. (1982) Modulation of a glycoprotein recognition system on rat hepatic endothelial cells by glucose and diabetes mellitus. J. Clin. Invest., 69, 1337-1347.